Literature DB >> 19189851

Retroviral self-inactivation in the mouse vagina induced by short DNA.

Lina Wittmer-Elzaouk1, Jiunshan Jung-Shiu, Jochen Heinrich, Karin Moelling.   

Abstract

Human immunodeficiency virus (HIV) has been shown to undergo self-destruction upon treatment of cell-free virions with partially double-stranded oligodeoxynucleotides targeting the polypurine tract (PPT) of the viral RNA in the virus particle. The ODN forms a local hybrid with the PPT activating the viral RNase H to prematurely cleave the genomic RNA. Here we are describing the self-destruction of a recombinant lentivirus harboring the PPT of HIV in a mouse vagina model. We showed a decrease in viral RNA levels in cell-free virus particles and a reduction reverse transcribed complementary DNA (cDNA) in virus-infected human and primary murine cells by incubation with ODNs. In the vagina simultaneous, prophylactic or therapeutic ODN treatments led to a significant reduction in viral RNA levels. Our finding may have some relevance for the design of other viral self-destruction approaches. It may lead to a microbicide for reduction of sexual and mother-to-child transmission.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19189851     DOI: 10.1016/j.antiviral.2009.01.002

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  3 in total

Review 1.  The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.

Authors:  Samuel Broder
Journal:  Antiviral Res       Date:  2009-12-16       Impact factor: 5.970

2.  Short hairpin-loop-structured oligodeoxynucleotides reduce HSV-1 replication.

Authors:  Alexander Falkenhagen; Jochen Heinrich; Karin Moelling
Journal:  Virol J       Date:  2009-04-27       Impact factor: 4.099

3.  Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide.

Authors:  Maike Voges; Carola Schneider; Malte Sinn; Jörg S Hartig; Rudolph Reimer; Joachim Hauber; Karin Moelling
Journal:  BMC Infect Dis       Date:  2016-07-22       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.